Majority of Women Lack Accurate Knowledge of Their Own Breast Cancer Risk
Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.
Diagnosis & Disease Information
Survey Identifies Modifiable Barriers to Mammography Screening Among Rural US Women
A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.
Perioperative MRI of Uncertain Benefit for Women with DCIS
The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is “uncertain,” found a study presented during BCS 2013.
Dr. Edith Perez’s Recommended Abstracts at BCS 2013
ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.
Radiotherapy for DCIS Is Not Associated With Increased Cardiovascular Disease
Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.
Patient Advocates Help Identify Patient-Reported Outcomes for Research
Workshops with patient advocates are a promising approach to identifying meaningful patient-reported outcome end points for clinical studies of breast cancer treatments, found research at BCS 2013.
Eribulin Outcomes ‘Comparable’ Regardless of Triple-Negative Status, Prior Anthracyclines
Eribulin safety and time to treatment failure in real-world clinical settings are comparable to those identified in previous clinical trials, found a study presented at BCS 2013.
T-DM1 for Metastatic Breast Cancer is Safe, Effective in Clinical Setting
T-DM1 is as safe and effective in previously treated patients with HER2+ metastatic breast cancer in clinical settings as it was in clinical trials, found research at BCS 2013.
Patients Prioritize Recurrence Assessment, Psychological Support at Post-Treatment Appointments
Most patients would prefer to receive assessments, support during follow-up appoints, but details of their preferences after treatment vary, found data presented at BCS 2013.
Premenopausal Status Associated with Weight Gain During Breast Cancer Chemotherapy
Weight gain during chemotherapy is associated with premenopausal status but not patient age, tumor histology or stage, or therapeutic regimens, found research at BCS 2013.
- Loading...
Loading...
Loading... 
Loading...